OTC · ANTH
Anthera Pharmaceuticals, Inc.
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Aug 23, 2026, 7:09 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.62K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.00
- Volume
- 812
- Avg. volume
- 5.56K
Price performance
ANTH price history
1M range · 6 trading sessions · Daily adjusted prices
ANTH closed at $0.00 after 6 trading sessions.
- Last close
- $0.00
- Period change
- —
- Period low
- $0.00
- Period high
- $0.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 19, 2026 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 812 |
| Aug 11, 2026 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 2.51K |
| Aug 10, 2026 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 108 |
| Aug 7, 2026 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 8.8K |
| Aug 5, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 200 |
| Aug 4, 2026 | $0.00 | $0.0001 | $0.00 | $0.00 | 15.25K |
Latest ANTH news
The latest Smart Investors Daily articles mentioning ANTH.
Stock researchCompany · Overview
ANTH research
Overview
Company profile and research snapshot.
Company profile
ANTHERA PHARMS INC NEW
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 21, 2018 | Roth Capital | Buy | — |
| Dec 29, 2016 | Citigroup | Neutral | — |
| Dec 29, 2016 | Jefferies | Hold | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
